![]() Aptus Clinical Aptus Clinical is a clinical contract research organization that specializes in oncology, rare diseases, and cell and gene therapies. | ![]() Bioheng Bioheng (also known as Nanjing Beiheng Biotech, 北恒生物) is a biopharmaceutical company that focuses on immunotherapy and gene therapy for treating cancer. | ![]() Nexomics Biosciences Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community. | CytoMed Therapeutics CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers. | ||
Founding Date | Founding Date 2014 | Founding Date 2017 | Founding Date 2007 | Founding Date 2013 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Alderley Edge, GB HQ | Locations Nanjing, CN HQ | Locations Rocky Hill, US HQ Mansfield, US | Locations Reykjavík, IS HQ Hannover, DE Jülich, DE Zürich, CH Arlington, US | Locations Singapore, SG HQ Masai, MY |
Employees | Employees 26 | Employees N/A | Employees 1220% increase | Employees 9837% increase | Employees 24 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 80m (about 5 years ago) | Latest funding round N/A | Latest funding round $ 50m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 94.8m | Total funding raised N/A | Total funding raised $ 50m | Total funding raised N/A |

Bioheng (also known as Nanjing Beiheng Biotech, 北恒生物) is a biopharmaceutical company that focuses on immunotherapy and gene therapy for treating cancer.
View company
Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community.
View companyAlvotech is a biopharmaceutical company focused on the creation of biosimilar medicines.
View companyCytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers.
View company